Abstract:Background: The tumour immune microenvironment plays an important role in the biological mechanisms of tumorigenesis and progression. Artificial intelligence medicine studies based on big data and advanced algorithms are helpful for improving the accuracy of prediction models of tumour prognosis. The current research aims to explore potential prognostic immune biomarkers and develop a predictive model for the overall survival of ovarian cancer (OC) based on artificial intelligence algorithms. Methods: Differential expression analyses were performed between normal tissues and tumour tissues. Potential prognostic biomarkers were identified using univariate Cox regression. An immune regulatory network was constructed of prognostic immune genes and their highly related transcription factors. Multivariate Cox regression was used to identify potential independent prognostic immune factors and develop a prognostic model for ovarian cancer patients. Three artificial intelligence algorithms, random survival forest, multitask logistic regression, and Cox survival regression, were used to develop a novel artificial intelligence survival prediction system. Results: The current study identified 1,307 differentially expressed genes and 337 differentially expressed immune genes between tumour samples and normal samples. Further univariate Cox regression identified 84 prognostic immune gene biomarkers for ovarian cancer patients in the model dataset (GSE32062 dataset and GSE53963 dataset). An immune regulatory network was constructed involving 63 immune genes and 5 transcription factors. Fourteen immune genes (PSMB9, FOXJ1, IFT57, MAL, ANXA4, CTSH, SCRN1, MIF, LTBR, CTSD, KIFAP3, PSMB8, HSPA5, and LTN1) were recognised as independent risk factors by multivariate Cox analyses. Kaplan-Meier survival curves showed that these 14 prognostic immune genes were closely related to the prognosis of ovarian cancer patients. A prognostic nomogram was developed by using these 14 prognostic immune genes. The concordance indexes were 0.760, 0.733, and 0.765 for 1-, 3-, and 5-year overall survival, respectively. This prognostic model could differentiate high-risk patients with poor overall survival from low-risk patients. According to three artificial intelligence algorithms, the current study developed an artificial intelligence survival predictive system that could provide three individual mortality risk curves for ovarian cancer. Conclusion: In conclusion, the current study identified 1,307 differentially expressed genes and 337 differentially expressed immune genes in ovarian cancer patients. Multivariate Cox analyses identified fourteen prognostic immune biomarkers for ovarian cancer. The current study constructed an immune regulatory network involving 63 immune genes and 5 transcription factors, revealing potential regulatory associations among immune genes and transcription factors. The current study developed a prognostic model to predict the prognosis of ovarian cancer patients. The current study further developed two artificial intelligence predictive tools for ovarian cancer, which are available at https://zhangzhiqiao8.shinyapps.io/Smart_Cancer_Survival_Predictive_System_17_OC_F1001/ and https://zhangzhiqiao8.shinyapps.io/Gene_Survival_Subgroup_Analysis_17_OC_F1001/ . An artificial intelligence survival predictive system could help improve individualised treatment decision-making.

Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma

Artificial intelligence predicts lung cancer radiotherapy response: A meta-analysis

[Clinical Study of Artificial Intelligence-assisted Diagnosis System in Predicting the Invasive Subtypes of Early-stage Lung Adenocarcinoma Appearing As Pulmonary Nodules].

AI-Enabled Lung Cancer Prognosis

A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies

Artificial Intelligence-Assisted Decision Making for Prognosis and Drug Efficacy Prediction in Lung Cancer Patients: a Narrative Review

Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer

An Artificial Intelligence Network-Guided Signature for Predicting Outcome and Immunotherapy Response in Lung Adenocarcinoma Patients Based on 26 Machine Learning Algorithms.

Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer

Interpretable deep learning survival predictive tool for small cell lung cancer

A Retrospective Diagnostic Test Study on Circulating Tumor Cells and Artificial Intelligence Imaging in Patients with Lung Adenocarcinoma

AI predictive modeling of survival outcomes for renal cancer patients undergoing targeted therapy

Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System

Integrated machine learning survival framework to decipher diverse cell death patterns for predicting prognosis in lung adenocarcinoma

A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis

The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma

A novel mitochondria-related algorithm for predicting the survival outcomes and drug sensitivity of patients with lung adenocarcinoma

Development and validation of a nomogram model for lung cancer based on radiomics artificial intelligence score and clinical blood test data

Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism

Developing Prognostic Gene Panel of Survival Time in Lung Adenocarcinoma Patients Using Machine Learning

An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma